New in the NCCN guidelines is lurbinectedin [Zepzelca] and atezolizumab [Tecentriq] maintenance. 2 There are other ...

Roswell Park researchers present a two-step, mechanism-based drug strategy at AACR 2026 that selectively targets cancers with ...

New research suggests hair loss may hinge on a fragile cellular balance during regeneration, where stem cells must survive a ...

As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...

The protein is implicated in a wide swath of cancers, but harnessing it for drug R&D is still a major scientific challenge.

The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling ...

In 1976, Richard Dawkins published a book titled after an idea he’d come up with while teaching a lecture on animal behaviour for his PhD supervisor. It just so happened that the idea of The Selfish ...

The TP53 gene is known to encode a powerful tumor suppressor, but alternative splicing of this gene also produces multiple isoforms whose biological functions remain poorly understood. Some of these ...

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a revolutionary new method to improve compact gene-editing tools known as base ...

Originally reported as an oncogene and currently known to be a major “genome guardian”, the p53 protein remains one of the most explored transcription factors, exhibiting variety of functions both ...

Dustin Vidrine's sight is disappearing — shrinking, really. He has retinitis pigmentosa, a rare, inherited eye disease that runs in his family. By the time he was in his 20s, he noticed that his ...